{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:49b893af-4724-463f-9428-d39ae6a409df","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-18T11:25:45.911307+00:00","published_at":"2026-10-18T07:12:26.240942+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:ws64ktijncad","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-02-11","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:enrique-poradosu","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:14f9951817e5cf29fcc1637d0a99b1c401d54353a321007c28927d94f4ffcaee"],"summary":"Enrique Poradosu executive of Nuvectis Pharma, Inc., effective 2026-02-11.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1al0e3oq7jzgm","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-02-11","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:michael-carson","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:ac03bb87cfa1544d66ce74cfa09018e7cbbb33e4f4e67f46566a9843c18029af"],"summary":"Michael Carson executive of Nuvectis Pharma, Inc., effective 2026-02-11.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ev4ass1wfm854","event_type":"CEO_CHANGED","effective_at":"2026-02-11","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:ron-bentsur","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:7b8808041a29c36944228fbfe3023401a30f29f46cd969ff03cf96ffa46103f5"],"summary":"Ron Bentsur executive of Nuvectis Pharma, Inc., effective 2026-02-11.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:loixle1nyrlu6","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-02-11","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:shay-shemesh","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:41d33a48e2eb35d831f43918e75a33a65e73aa42e737ae63991d1fec977d0f9f"],"summary":"Shay Shemesh executive of Nuvectis Pharma, Inc., effective 2026-02-11.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15vxrwebxirfq","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:james-f-oliviero-iii","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"James F. Oliviero, III seat on Nuvectis Pharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:bwogef1ykx","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:kenneth-hoberman","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"Kenneth Hoberman seat on Nuvectis Pharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:c57qvw66psxw","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:matthew-kaplan","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"Matthew Kaplan seat on Nuvectis Pharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:e5p3suuor1p2","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:committee:nuvectis-pharma-inc:audit-chair-compensation","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"Audit · Chair; Compensation committee of Nuvectis Pharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1isfmfqx5ymp","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:james-f-oliviero-iii","alpha:committee:nuvectis-pharma-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"James F. Oliviero, III member of Audit · Chair; Compensation, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:rm618k1t7aot8","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:committee:nuvectis-pharma-inc:audit-compensation","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"Audit; Compensation committee of Nuvectis Pharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ngk66hlxjqfz","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:matthew-kaplan","alpha:committee:nuvectis-pharma-inc:audit-compensation"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"Matthew Kaplan member of Audit; Compensation, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:yamyo91ro5lol","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:committee:nuvectis-pharma-inc:audit-compensation-chair","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"Audit; Compensation · Chair committee of Nuvectis Pharma, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kxi03ajza3qm","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:kenneth-hoberman","alpha:committee:nuvectis-pharma-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"Kenneth Hoberman member of Audit; Compensation · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qk8p0q122f5uq","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-18T07:12:26.240942+00:00","subject_ids":["alpha:person:ron-bentsur","alpha:company:49b893af-4724-463f-9428-d39ae6a409df"],"caused_claim_ids":["alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72"],"summary":"Ron Bentsur seat on Nuvectis Pharma, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:5","subject_id":"alpha:company:49b893af-4724-463f-9428-d39ae6a409df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-f-oliviero-iii","object_label":"James F. Oliviero, III","object_source_name_forms":[],"value":"James F. Oliviero, III: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-f-oliviero-iii","name":"James F. Oliviero, III"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-18T07:12:26.240942+00:00","sources":[{"id":"alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Nuvectis Pharma, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:02.059+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-18T07:12:26.240942+00:00","reviewed_at":"2026-10-18T07:12:26.240942+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:6","subject_id":"alpha:company:49b893af-4724-463f-9428-d39ae6a409df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kenneth-hoberman","object_label":"Kenneth Hoberman","object_source_name_forms":[],"value":"Kenneth Hoberman: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kenneth-hoberman","name":"Kenneth Hoberman"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-18T07:12:26.240942+00:00","sources":[{"id":"alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Nuvectis Pharma, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:02.059+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-18T07:12:26.240942+00:00","reviewed_at":"2026-10-18T07:12:26.240942+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:7","subject_id":"alpha:company:49b893af-4724-463f-9428-d39ae6a409df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:matthew-kaplan","object_label":"Matthew Kaplan","object_source_name_forms":[],"value":"Matthew Kaplan: Director, Audit; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:matthew-kaplan","name":"Matthew Kaplan"},"title":"Director","role_category":"director","committee":"Audit; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-18T07:12:26.240942+00:00","sources":[{"id":"alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Nuvectis Pharma, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:02.059+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-18T07:12:26.240942+00:00","reviewed_at":"2026-10-18T07:12:26.240942+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:8","subject_id":"alpha:company:49b893af-4724-463f-9428-d39ae6a409df","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ron-bentsur","object_label":"Ron Bentsur","object_source_name_forms":[],"value":"Ron Bentsur: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ron-bentsur","name":"Ron Bentsur"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-18T07:12:26.240942+00:00","sources":[{"id":"alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Nuvectis Pharma, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:02.059+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-28","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-18T07:12:26.240942+00:00","reviewed_at":"2026-10-18T07:12:26.240942+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:9","subject_id":"alpha:company:49b893af-4724-463f-9428-d39ae6a409df","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:enrique-poradosu","object_label":"Enrique Poradosu","object_source_name_forms":[],"value":"Enrique Poradosu: Executive Vice President, Chief Scientific and Business Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:enrique-poradosu","name":"Enrique Poradosu"},"title":"Executive Vice President, Chief Scientific and Business Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-11","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-11","valid_to":null,"recorded_at":"2026-10-18T07:12:26.240942+00:00","sources":[{"id":"alpha:projection-evidence:document:14f9951817e5cf29fcc1637d0a99b1c401d54353a321007c28927d94f4ffcaee","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVCT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-16T06:12:55.203932+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-11T00:00:00+00:00","effective_from":"2026-02-11","effective_until":null,"observed_at":"2026-10-18T07:12:26.240942+00:00","reviewed_at":"2026-10-18T07:12:26.240942+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:10","subject_id":"alpha:company:49b893af-4724-463f-9428-d39ae6a409df","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-carson","object_label":"Michael Carson","object_source_name_forms":[],"value":"Michael Carson: Vice President of Finance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-carson","name":"Michael Carson"},"title":"Vice President of Finance","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-11","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-11","valid_to":null,"recorded_at":"2026-10-18T07:12:26.240942+00:00","sources":[{"id":"alpha:projection-evidence:document:ac03bb87cfa1544d66ce74cfa09018e7cbbb33e4f4e67f46566a9843c18029af","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVCT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-16T06:12:56.176313+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-11T00:00:00+00:00","effective_from":"2026-02-11","effective_until":null,"observed_at":"2026-10-18T07:12:26.240942+00:00","reviewed_at":"2026-10-18T07:12:26.240942+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:11","subject_id":"alpha:company:49b893af-4724-463f-9428-d39ae6a409df","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:ron-bentsur","object_label":"Ron Bentsur","object_source_name_forms":[],"value":"Ron Bentsur: Chairman, Chief Executive Officer and President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:ron-bentsur","name":"Ron Bentsur"},"title":"Chairman, Chief Executive Officer and President","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-11","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-11","valid_to":null,"recorded_at":"2026-10-18T07:12:26.240942+00:00","sources":[{"id":"alpha:projection-evidence:document:7b8808041a29c36944228fbfe3023401a30f29f46cd969ff03cf96ffa46103f5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVCT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-16T06:12:54.65673+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-11T00:00:00+00:00","effective_from":"2026-02-11","effective_until":null,"observed_at":"2026-10-18T07:12:26.240942+00:00","reviewed_at":"2026-10-18T07:12:26.240942+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:49b893af-4724-463f-9428-d39ae6a409df:leadership_role:12","subject_id":"alpha:company:49b893af-4724-463f-9428-d39ae6a409df","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:shay-shemesh","object_label":"Shay Shemesh","object_source_name_forms":[],"value":"Shay Shemesh: Executive Vice President, Chief Development and Operations Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:shay-shemesh","name":"Shay Shemesh"},"title":"Executive Vice President, Chief Development and Operations Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-02-11","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-02-11","valid_to":null,"recorded_at":"2026-10-18T07:12:26.240942+00:00","sources":[{"id":"alpha:projection-evidence:document:41d33a48e2eb35d831f43918e75a33a65e73aa42e737ae63991d1fec977d0f9f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVCT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-16T06:12:55.692827+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-02-11T00:00:00+00:00","effective_from":"2026-02-11","effective_until":null,"observed_at":"2026-10-18T07:12:26.240942+00:00","reviewed_at":"2026-10-18T07:12:26.240942+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:f055be2e5475cf6055986058302903670547a0c5f013721891fb4609e2349f72","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Nuvectis Pharma, Inc. DEF 14A 2025-04-28","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465925040225/tm252541-4_def14a.htm","source_date":"2025-04-28","retrieved_at":"2026-04-28T23:42:02.059+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:14f9951817e5cf29fcc1637d0a99b1c401d54353a321007c28927d94f4ffcaee","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVCT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-16T06:12:55.203932+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ac03bb87cfa1544d66ce74cfa09018e7cbbb33e4f4e67f46566a9843c18029af","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVCT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-16T06:12:56.176313+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7b8808041a29c36944228fbfe3023401a30f29f46cd969ff03cf96ffa46103f5","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVCT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-16T06:12:54.65673+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:41d33a48e2eb35d831f43918e75a33a65e73aa42e737ae63991d1fec977d0f9f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"NVCT 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1875558/000110465926013044/tmb-20251231x10k.htm","source_date":"2026-02-11T00:00:00+00:00","retrieved_at":"2026-05-16T06:12:55.692827+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.87,"cross_source_agreement":0.75,"temporal_completeness":0.571},"diagnostics":{"published_claims":20,"factual_claims":20,"claims_with_linked_evidence":20,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":14,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-18T07:12:26.240942+00:00","observed_at":"2026-10-18T07:12:26.240942+00:00","reviewed_at":"2026-10-18T07:12:26.240942+00:00","verified_at":"2026-10-18T07:12:26.240942+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":20,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/nuvectis-pharma-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/nuvectis-pharma-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}